bluebird bio, Inc. Made Big Gain
Wed, Dec 04, 2024 at 07:30 PM
bluebird bio, Inc. (BLUE:NASDAQ) jumped higher at $0.74, representing a gain of 105.4%. On Wed, Dec 04, 2024, BLUE:NASDAQ hit a New 2-Week High of $0.74. The stock appeared on our News Catalysts scanner on Wed, Dec 04, 2024 at 05:02 PM in the 'SPLIT' category. From Wed, Nov 20, 2024, the stock recorded 66.67% Up Days and 50.00% Green Days
The stock spiked on Tue, Jul 16, 2024 at $1.43 with a volume of 9M+.
About bluebird bio, Inc. (BLUE:NASDAQ)
bluebird bio Inc is a clinical-stage biotechnology company which develops gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy.
Top 10 Gainers:
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 294.41%
- bluebird bio, Inc. (BLUE:NASDAQ), 105.38%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 105.34%
- SRM Entertainment Inc. (SRM:NASDAQ), 84.1%
- Cross Country Healthcare, Inc. (CCRN:NASDAQ), 62.72%
- CN Energy Group Inc. (CNEY:NASDAQ), 61.68%
- Power REIT (PW:NYSEMKT), 51.72%
- Perfect Moment Ltd. (PMNT:NYSEMKT), 46.75%
- Snail, Inc. (SNAL:NASDAQ), 46.67%
- Reitar Logtech Holdings Limited (RITR:NASDAQ), 41.42%